Physician profile
Markus E Laney
NPI 1326091034
$426.56
in general payments reported to CMS, 2019-2025
18 companies · $35.02 in 2025
The $35.02 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $45.53 · 2021: $41.80 · 2022: $60.89 · 2023: $61.69 · 2024: $15.43 · 2025: $35.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $84.20 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $45.29 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.50 | 2019 | |
| Seqirus USA INC | $28.29 | 2023 | Flucelvax Quadrivalent |
| Ironshore Pharmaceuticals INC. | $27.76 | 2019 | |
| Genentech USA, INC. | $27.21 | 2019 | |
| Verrica Pharmaceuticals INC. | $19.58 | 2025 | Ycanth |
| Tris Pharma INC | $19.57 | 2020 | |
| Supernus Pharmaceuticals, INC. | $17.71 | 2021 | |
| Kaleo, INC. | $16.21 | 2019 | |
| Sobi, INC | $15.60 | 2022 | |
| Sanofi Pasteur INC. | $15.55 | 2023 | |
| Glaxosmithkline, LLC. | $15.44 | 2025 | Penmenvy, Bexsero |
| Cranial Technologies, INC | $15.43 | 2024 | Doc Band |
| Shire North American Group INC | $13.98 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $12.79 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.30 | 2021 | |
| Mission Pharmacal Company | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Markus Laney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.